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Abstract
Background: Retinal ganglion cells (RGCs), the output neurons of the retina, project to over 20 distinct brain nuclei,
including the lateral geniculate nucleus (LGN), a thalamic region comprised of three functionally distinct subnuclei:
the ventral LGN (vLGN), the dorsal LGN (dLGN) and the intergeniculate leaflet (IGL). We previously identified reelin,
an extracellular glycoprotein, as a critical factor that directs class-specific targeting of these subnuclei. Reelin is
known to bind to two receptors: very-low-density lipoprotein receptor (VLDLR) and low-density lipoprotein
receptor-related protein 8 (LRP8), also known as apolipoprotein E receptor 2 (ApoER2). Here we examined the roles
of these canonical reelin receptors in retinogeniculate targeting.
Results: To assess the roles of VLDLR and LRP8 in retinogeniculate targeting, we used intraocular injections of
fluorescently conjugated cholera toxin B subunit (CTB) to label all RGC axons in vivo. Retinogeniculate projections in
mutant mice lacking either VLDLR or LRP8 appeared similar to controls; however, deletion of both receptors
resulted in dramatic defects in the pattern of retinal innervation in LGN. Surprisingly, defects in vldlr−/−;lrp8−/− double
mutant mice were remarkably different than those observed in mice lacking reelin. First, we failed to observe retinal
axons exiting the medial border of the vLGN and IGL to invade distant regions of non-retino-recipient thalamus.
Second, an ectopic region of binocular innervation emerged in the dorsomedial pole of vldlr−/−;lrp8−/− mutant dLGN.
Analysis of retinal projection development, retinal terminal sizes and LGN cytoarchitecture in vldlr−/−;lrp8−/− mutants, all
suggest that a subset of retinal axons destined for the IGL are misrouted to the dorsomedial pole of dLGN in the
absence of VLDLR and LRP8. Such mistargeting is likely the result of abnormal migration of IGL neurons into the
dorsomedial pole of dLGN in vldlr−/−;lrp8−/− mutants.
Conclusions: In contrast to our expectations, the development of both the LGN and retinogeniculate projections
appeared dramatically different in mutants lacking either reelin or both canonical reelin receptors. These results
suggest that there are reelin-independent functions of VLDLR and LRP8 in LGN development, and VLDLR- and
LRP8-independent functions of reelin in class-specific axonal targeting.
Keywords: Reelin, Synaptic targeting, Intergeniculate nucleus, Retinogeniculate, Lateral geniculate nucleus, Axon,
Retinal terminal

Background
Neural circuits associated with retinal ganglion cells (RGCs)
have long been used as models for investigating the mechanisms that underlie circuit development and function. As
the sole output neurons of the retina, RGCs must convey
information regarding color, contrast, light intensity and
object movement to specific regions within retino-recipient
nuclei of the brain. For this reason, RGC axons project to
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over 20 distinct central nervous system (CNS) nuclei and
are targeted to these sites by at least three distinct
mechanisms. First, retinal axons are sorted topographically, so that the location of information in the visual
field is accurately conveyed to a spatially correlated region
of a retino-recipient nucleus [1]. Ephs/ephrins, morphogens
and transmembrane cell adhesion molecules all contribute
to topographic targeting of retinal axons in the mammalian
brain [1-3]. In addition to being topographically mapped,
retinal axons are sorted into discrete domains of most
retino-recipient nuclei based upon their eye of origin.
The formation of eye-specific domains requires both
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axonal targeting cues (such as Eph/ephrins and teneurins)
[4-6], and subsequent activity-dependent refining signals
(such as MHC1, C1q and neuronal pentraxins) [7-10]. The
third targeting mechanism involves axons from different
functional classes of RGCs targeting distinct retinorecipient nuclei or different lamina (or domains) with
these nuclei. Although axonal projection patterns have
recently been described for several classes of RGCs
[11-19], few studies have shed light on the mechanisms
underlying such class-specific targeting [20]. We recently
identified reelin as a critical regulator of class-specific
retinogeniculate targeting.
Reelin is a bulky, extracellular glycoprotein composed
of an N-terminal f-spondin domain, eight repeated unique
domains containing epidermal growth factor (EGF)-like
motifs and a C-terminal domain rich in positively charged
amino acids [21,22]. A multitude of studies have shown
roles for reelin in neuronal migration, axonal polarization,
dendritic arborization and spine formation, growth cone
guidance, axonal targeting, and synaptic function and
plasticity [21-30]. We previously identified reelin in a
screen for synaptic targeting cues that were differentially
expressed in subnuclei of the lateral geniculate nucleus
(LGN): the ventral LGN (vLGN), the dorsal LGN (dLGN)
and the intergeniculate leaflet (IGL) [31]. Reelin is significantly enriched in vLGN and IGL during retinogeniculate
circuit formation, and mice lacking reelin (relnrl/rl) exhibit severe defects in retinal targeting of these regions
[31]. Targeting defects in relnrl/rl mutants result from the
mistargeting of intrinsically photosensitive RGC (ipRGC)
axons, whereas axons from other classes of RGCs appear
unaffected by the absence of reelin [31].
Most functions of reelin have been attributed to its
ability to bind two members of the low- density lipoprotein
(LDL) receptor gene family: very-low-density lipoprotein
receptor (VLDLR) and low-density lipoprotein receptorrelated protein 8 (LRP8), also known as apolipoprotein E
receptor 2 (ApoER2) [32,33]. Upon binding reelin, VLDLR
and LRP8 activate the intracellular adaptor molecule
disabled-1 (DAB1) [32]. Genetic deletion of both VLDLR
and LRP8 or DAB1 result in mutant mice that outwardly
resemble relnrl/rl mutants [32,34-36]. Our previous studies
on visual system development partially confirmed a similar
molecular signaling pathway underlies reelin's function in
retinal targeting: mice harboring a spontaneous mutation in
DAB1 exhibit similar defects in retinogeniculate targeting
as relnrl/rl mutants [31]. In the present study we sought
to expand these findings and test the roles of VLDLR
and LRP8 in retinogeniculate targeting. We hypothesized that deletion of both canonical reelin receptors
would produce defects in retinal targeting that closely
resembled those in the absence of reelin. To our surprise,
however, defects observed in mice lacking both VLDLR and
LRP8 (vldlr−/−;lrp8−/−) were strikingly different than those
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in reeler mutants. Results presented here suggest that
there are both reelin-independent functions of VLDLR
and LRP8, and VLDLR- and LRP8-independent functions
of reelin in visual system development.

Results
Deletion of both VLDLR and LRP8 disrupts
retinogeniculate targeting

To assess the roles of VLDLR and LRP8 in retinogeniculate
targeting we analyzed retinal projections in vldlr−/− and
lrp8−/− mutant mice. These mice are viable, fertile, and
their appearance and cage behavior are indistinguishable
from wild-type and heterozygote littermates. Intraocular injections of fluorescently conjugated cholera toxin B subunit
(CTB) were used to label all RGC axons. Axonal projections were analyzed during the second and third postnatal
weeks of mouse development, a period of development
when retinal axons have fully innervated the dLGN,
vLGN and IGL (Figure 1A). Projections from each eye
were labeled with distinct fluorescently conjugated versions
of CTB, so that eye-specific projections could be distinguished in the LGN. In contrast to mutants lacking reelin
(Figure 1B), the gross pattern of retinal projections to each
LGN subnuclei in mutants lacking either VLDLR or LRP8
appeared similar to those observed in littermate controls in
many regards (Figure 1C,D). Specifically, retinal axons fully
arborized in the IGL, and no retinal axons were observed
exiting the medial border of the vLGN or IGL and invading non-retino-recipient regions of medial thalamus
(Figure 1C,D and see arrowheads in 1B) (Table 1).
Although these gross patterns of retinal innervation
in vldlr−/− and lrp8−/− mutant mice appeared similar to littermate controls, the absence of these receptors (and reelin)
clearly affected activity-dependent refinement of retinal
projections into fully segregated, eye-specific domains
in both vLGN and dLGN.
Previous studies have demonstrated that VLDLR and
LRP8 are capable of compensating for each other [32].
For this reason, we explored whether deletion of both
VLDLR and LRP8 affects retinogeniculate targeting.
Vldlr−/−;lrp8−/− double mutant mice are born in
expected ratios and are indistinguishable from littermate
controls (or vldlr−/− or lrp8−/− single mutants) at birth. By
the end of the first week of postnatal development, vldlr−/−;
lrp8−/− mutants appeared smaller than littermates and by
postnatal day 12 (P12) double mutants exhibited an ataxic
gait (similar to relnrl/rl mutants). Retinal projections
were labeled by intraocular injection of CTB in P9 to
P23 vldlr−/−;lrp8−/− mutants (n = 6). Several defects in
retinal projections in the absence of both VLDLR and
LRP8 appeared similar to defects observed in mutants
lacking reelin (Figure 1B and 2B,C). Specifically, the
spatial extent of retinal innervation to vLGN and IGL
appeared markedly decreased in vldlr−/−;lrp8−/− mutants
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Figure 1 Retinogeniculate projections in wild-type, relnrl/rl, vldlr−/− and lrp8−/−mice. Retinogeniculate projections in (A) P14 controls, (B) P14
relnrl/rl mutants, (C) P13 vldlr−/− mutants and (D) P13 lrp8−/− mutants were labeled by intraocular injection of fluorescently conjugated CTB. Left
eyes were injected with Alexa Fluor 594 CTB and right eyes were injected with Alexa Fluor 488 CTB. LGN from right hemispheres are shown. In
P14 relnrl/rl mutants (B), note the near absence of retinal projections to the IGL, and the bundle of labeled retinal axons extending out of the LGN
and into non-retino-recipient thalamus (arrowheads). ‘Contra’ denotes projections originating from the contralateral retina and ‘ipsi’ denotes
projections originating from the ipsilateral retina. dLGN are labeled ‘d’, vLGN are labeled ‘v’ and arrows indicate IGL. The color of the label in
panels (A to D) and (A’ to D’) indicates the color of the image shown in (A” to D”). Scale bar = 200 μm. CTB, cholera toxin B subunit; dLGN,
dorsal LGN; IGL, intergeniculate leaflet; LGN, lateral geniculate nucleus; vLGN, ventral LGN.

(Figure 2B,C). Additionally, a region that lacked retinal
arbors appeared to separate the vLGN and IGL in vldlr−/−;
lrp8−/− mutants (Figure 2B,C). Despite these similarities

with retinogeniculate targeting in the absence of reelin,
we were surprised to find that a well-defined set of retinal
projections to the IGL persisted in vldlr−/−;lrp8−/−
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Table 1 Retinogeniculate projection in phenotypes in wild-type and mutant mice
Genotype

Smaller retino-recipient
region of vLGN

Sparse retinal
projections to IGL

Misrouted retinal axons
exiting medial border of LGN

Ectopic retinal
projections in dLGN

Control

-

-

-

-

(0/11)

(0/11)

(0/11)

(0/11)

++

++

++

-

7/7

(7/7)

(7/7)

(0/7)

-

-

-

+/−

(0/11)

(0/11)

(0/11)

(2/11)

-

-

-

-

(0/9)

(0/9)

(0/9)

(0/9)

-

-

-

-

(0/9)

(0/9)

(0/9)

(0/9)

-

+

-

+

(0/6)

(2/6)

(0/6)

(2/6)

+/−

+

+/−

+

(4/7)

(3/7)

(1/7)

(5/7)

++

++

+/−

++

(7/7)

(7/7)

(2/7)

(7/7)

relnrl/rl
vldlr−/−
lrp8−/−
vldlr+/−;lrp8+/−
vldlr+/−;lrp8−/−
vldlr−/−;lrp8+/−
vldlr−/−;lrp8−/−

The presence of four distinct defects in retinogeniculate projection patterns was assessed in various mutant mice: 1) small retinal projection patterns to vLGN; 2) a
region of sparse retinal projections in or adjacent to IGL; 3) retinal axons misrouted out of the medial border of the vLGN and IGL; and 4) an ectopic region of
binocular retinal projections in the dorsomedial pole of dLGN. Phenotypes were scored as being: −, absent; +/−, weak and only occasionally present; +, strong but
only occasionally present; and ++, strong and highly penetrant. Parentheses indicate the number of mice exhibiting a phenotype compared to the total number
of mice analyzed for that genotype. All mice included in these analyses ranged in age from P9 to P23. dLGN, dorsal LGN; IGL, intergeniculate leaflet; LGN, lateral
geniculate nucleus; vLGN, ventral LGN.

mutants and very few retinal axons were observed exiting
the medial border of the double mutant vLGN or IGL
(Figure 2B,C and Table 1). In the few vldlr−/−;lrp8−/−
mutants (two out of six) where such misrouted axons
were observed they were seen only in a small number of
coronal LGN sections and were typically single axons
that extended less than 100 μm from the LGN. These
rare misrouted axons differed dramatically from the
consist bundles of misrouted axons observed in relnrl/rl
mutants that extend for several hundred microns outside of
the LGN (see Figure 1B).
Unexpectedly, two defects were observed in retinal
projections in vldlr−/−;lrp8−/− mutants that we failed to
observe in the >20 relnrl/rl mutants we have previously
analyzed. First, dense patches of retinal arbors originating
from the contralateral eye were directly adjacent to,
and in some cases embedded within, the optic tract
(see arrowheads in Figure 2B,C). Second, an ectopic
patch of retinal arbors was present in the dorsomedial
pole of dLGN (see asterisks in Figure 2B,C). Although
this region of ectopic innervation was most commonly
observed in the dorsomedial pole of mutant dLGN, it
appeared to invade a more lateral portion of dLGN in
extreme rostral sections of mutant LGN (Figure 3).
Retinal arbors in these ectopic regions of innervation
originated from both contra- and ipsilateral retinas,
and were not segregate into eye-specific domains.

In the process of generating vldlr−/−;lrp8−/− mutants, a
large number of single reelin receptor gene mutants
were generated that carried only one copy of the other
canonical reelin receptor (vldlr−/−;lrp8+/− and vldlr+/−;
lrp8−/− mice). We analyzed retinal projections in these
mice to test the affect of gene dosage of these receptors
on retinal targeting. All of the defective phenotypes
described above for double mutants were observed in
mutant heterozygote mice, although phenotypes were
typically not as dramatic and not as penetrant as in
double mutants (Table 1).
Deletion of both VLDLR and LRP8 misroutes retinal axons
to the dorsomedial pole of dLGN

We next set out to understand the mechanisms that
underlie the formation of the ectopic, binocularly innervated region of dorsomedial dLGN in vldlr−/−;lrp8−/−
mutants. At perinatal ages (P3 to P4) projections from
both eyes form diffuse, overlapping arbors in wild-type
dLGN and vLGN. Similar diffuse projections were observed
from ipsi- and contralateral retinas in vldlr−/− mutants,
lrp8−/− mutants, and vldlr−/−;lrp8−/− double mutants
(Figure 4). Two striking defects were observed in retinal
projections at perinatal ages in vldlr−/−;lrp8−/− mutants.
First, a lack of arbors was observed in the region separating
the IGL and vLGN, similar to projections in relnrl/rl
mutants at this age (although no axons were observed
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Figure 2 Deletion of both VLDLR and LRP8 results in dramatic defects in retinogeniculate projections. Retinogeniculate projections in
(A) P19 control, (B) P19 vldlr−/−;lrp8−/− double mutant and (C) P16 vldlr−/−;lrp8−/− double mutant mice were labeled by intraocular injection of
fluorescently conjugated CTB. In vldlr−/−;lrp8−/− double mutants (B,C), note the absence of projection between the IGL and vLGN, the ectopic
clusters of retinal arbors adjacent to the optic tract (arrowheads), and the ectopic region of binocular retinal input in the dorsomedial pole of the
dLGN (asterisks). Double asterisks (**) indicate regions where retinal arbors from the ipsilateral retina have not been fully refined into segregated,
eye-specific domains. (D) High magnification views of the boxed region in (C). Blue and yellow arrowheads in (D) highlight differences in retinal
terminal size in dLGN (yellow) and the ectopic region at the dorsomedial pole of dLGN (blue). Left eyes were injected with Alexa Fluor 594 CTB
and right eyes were injected with Alexa Fluor 488 CTB. LGN from right hemispheres are shown. ‘Contra’ denotes projections originating from the
contralateral retina and ‘ipsi’ denotes projections originating from the ipsilateral retina. dLGN are labeled ‘d’, vLGN are labeled ‘v’ and arrows
indicate IGL. The color of the label in panels (A to D) and (A’ to D’) indicates the color of the image shown in (A” to D”). Scale bar = 200 μm for
(A to C) and 75 μm for (D). CTB, cholera toxin B subunit; dLGN, dorsal LGN; IGL, intergeniculate leaflet; LGN, lateral geniculate nucleus; LRP8, lowdensity lipoprotein receptor-related protein 8; VLDLR, very-low-density lipoprotein receptor; vLGN, ventral LGN.

exiting the medial border of vLGN and IGL in vldlr−/−;
lrp8−/− mutants (n = 3)). Second, retinal axons appeared
to innervate a distinct patch of thalamus that was dorsal
to the dLGN in vldlr−/−;lrp8−/− mutants (Figure 4D,F).

Projections to this ectopic region originated from both ipsiand contralateral retinas. These findings supported the
notion that retinal axons were initially mistargeted into the
dorsomedial pole of dLGN in vldlr−/−;lrp8−/− mutants.

Su et al. Neural Development 2013, 8:11
http://www.neuraldevelopment.com/content/8/1/11

Page 6 of 16

Figure 3 Retinogeniculate projections in rostral and caudal sections of vldlr−/−;lrp8−/− dLGN. Retinogeniculate projections in a P16 vldlr−/−;
lrp8−/− mutant were labeled by intraocular injection of fluorescently conjugated CTB. The left eye was injected with Alexa Fluor 594 CTB and the
right eye was injected with Alexa Fluor 488 CTB. Several sections of the same LGN from rostral to caudal are shown. Projections originating from
the contralateral retina are labeled in red and projections originating from the ipsilateral retina are labeled in green. Arrowheads indicate regions
of binocular, abnormal retinal projections. In central and caudal LGN sections, this region of ectopic innervation is in the dorsomedial pole of
mutant dLGN. However, in extreme caudal sections, the ectopic innervation invades more lateral dLGN regions. Scale bar = 200 μm. CTB, cholera
toxin B subunit; dLGN, dorsal LGN; LGN, lateral geniculate nucleus.

Figure 4 Development of retinogeniculate projections in wild-type, vldlr−/−, lrp8−/− and vldlr−/−;lrp8−/−mice. Retinogeniculate projections
in (A) P3 controls, (B) P3 lrp8−/− mutants, (C) P4 vldlr−/− mutants and (D) P3 vldlr−/−;lrp8−/− mutants were labeled by intraocular injection of
fluorescently conjugated CTB. In (D), note the ectopic region of binocular retinal input in the dorsomedial pole of vldlr−/−;lrp8−/− dLGN is labeled
with arrowheads. (E,F) High magnification images of the areas indicated by boxes in (A) and (D), respectively. Left eyes were injected with Alexa
Fluor 594 CTB and right eyes were injected with Alexa Fluor 488 CTB. LGN from right hemispheres are shown. ‘Contra’ denotes projections
originating from the contralateral retina and ‘ipsi’ denotes projections originating from the ipsilateral retina. dLGN are labeled ‘d’, vLGN are
labeled ‘v’ and arrows indicate IGL. The color of the label in panels (A to D) and (A’ to D’) indicates the color of the image shown in (A” to D”).
Scale bar = 200 μm for (A to D) and 75 μm for (E,F). CTB, cholera toxin B subunit; dLGN, dorsal LGN; IGL, intergeniculate leaflet; LGN, lateral
geniculate nucleus; vLGN, ventral LGN.
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Further support for the idea that retinal axons were
misrouted into the dorsomedial pole of dLGN in double
mutants came from two observations regarding the
morphology of CTB-labeled terminals in the ectopic
patch of retinal innervation in dLGN. First, as noted
above, retinal arbors appeared unsegregated based
upon their eye of origin, a feature normally common
only to those arbors within the IGL. Second, terminals
in the dorsomedial pole of double mutant dLGN
appeared morphologically smaller than other retinal
terminals in dLGN (Figure 2D). We verified this result
by labeling retinal terminals with antibodies against
vesicular glutamate transporter 2 (VGluT2), a synaptic
vesicle-associated protein whose distribution in LGN is
restricted to retinal terminals [37]. Importantly, VGluT2 is
specifically enriched in terminals and is largely absent from
non-synaptic regions of axons. VGluT2-immunostaining
revealed that retinal terminals in wild-type dLGN were
considerably larger than their counterparts in vLGN and
IGL (Figure 5A); and, as noted previously [38], the intensity
of VGluT2-immnoreactivity was considerably less robust
in wild-type IGL than in the adjacent vLGN and dLGN
(Figure 5A). Similar differences in terminal size were
observed in retinal terminals in vLGN, IGL and dLGN in
vldlr−/−;lrp8−/− mutants (Figure 5B). Analysis of the ectopic region of retinal innervation in the dorsomedial pole
of vldlr−/−;lrp8−/− mutant dLGN revealed terminal size
was morphologically and quantitatively similar to terminals in control vLGN and IGL rather than those in the
dLGN (Figure 5C to J). Taken together with developmental analyses, these data suggest that the ectopic region of
retinal innervation in vldlr−/−;lrp8−/− mutants resulted
from defects in axonal targeting and not from aberrant
retinal refinement.
Cytoarchitectural defects in the LGN of vldlr−/−;lrp8−/−
mutants

We next sought to understand if cytoarchitectural changes
in the LGN of vldlr−/−;lrp8−/− mutants might underlie
mistargeting of retinal axons into the dorsomedial pole of
dLGN. For this we assessed the expression of a disintegrin
and metalloproteinase with thrombospondin motif 15
(ADAMTS15). We previously identified adamts15 mRNA
as a reliable marker of dLGN neurons [31]. In situ
hybridization confirmed the enrichment of adamts15
mRNA in wild-type dLGN neurons, and its absence
from vLGN and IGL (Figure 6A). In vldlr−/−;lrp8−/−
mutants, adamts15 mRNA was similarly absent from
vLGN and IGL, and enriched throughout much of the
dLGN (Figure 6B). Importantly, however, it appeared
absent from the dorsomedial pole of the mutant dLGN
where ectopic retinal arbors were present (Figure 6B).
This suggested that dLGN relay neurons were absent from
this region of mutant dLGN. We confirmed these results
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with an antibody directed against non-phosphorylated
neurofilaments (SMI32), which has previously been shown
to specifically label relay neurons and their dendrites
in mouse dLGN and vLGN (but not in IGL) [31,39].
Immunostaining of wild-type P14 LGN produced a characteristic label of dLGN and vLGN neuropil (Figure 6C).
In vldlr−/−;lrp8−/− mutants similar reactivity was noted, with
two exceptions: 1) little, if any, SMI32-immunoreactivity
(SMI32-IR) was observed in the dorsomedial pole of the
double mutant dLGN (Figure 6D, see single asterisk);
and 2) SMI32-IR neurons were observed extending into
the medial border of the double mutant IGL (Figure 6D,
see arrowhead).
To further confirm cytoarchitectural differences in the
dorsomedial pole of vldlr−/−;lrp8−/− mutant dLGN, we
next assessed the presence of other types of nerve terminals
present in dLGN. A large portion of inputs to dLGN arise
from corticothalamic (CT) axons originating from layer VI
of visual cortex [40]. Terminals from these CT axons
contain the synaptic vesicle associated protein, vesicular glutamate transporter 1 (VGluT1) [37,41]. While
dense populations of VGluT1-containing terminals were
present throughout the dorsal thalamus and dLGN of
vldlr−/−;lrp8−/− mutants, they appeared absent from the
dorsomedial pole of mutant dLGN (Figure 6F). Taken together, studies on the distribution of adamts15 mRNA,
SMI32-IR and VGluT1-containing terminals all suggest
that the dorsomedial pole of vldlr−/−;lrp8−/− mutant
dLGN is cytoarchitecturally different than adjacent regions of dLGN.
Since dLGN relay neurons appeared absent from the
dorsomedial pole of mutant dLGN, we next asked
whether any neurons were present in this region. Indeed,
neuronal nuclei (NeuN) immunolabeling (which labels
most neurons in mouse brain) revealed a normal density of
neurons in mutant dLGN, including its dorsomedial pole
(Figure 7A,B,C). Since neurons in the mutant dorsomedial
pole lacked relay neuron markers we asked what their
identity might be. First, we applied riboprobes against
synaptotagmin 2 mRNA (syt2), a marker of vLGN neurons
[31], to assess whether neurons in the dorsomedial pole
of mutant dLGN may be derived from the vLGN. No syt2expressing neurons were detected in the dorsomedial pole
of mutant dLGN (data not shown). Next, we addressed
whether these displaced neurons might be from the
IGL, a possibility that seemed reasonable since IGL
neurons do not express adamts15 mRNA and are not
labeled by SMI32 antibodies [31]. Additionally, aberrant retinal projections in the mutant dorsomedial
dLGN pole fail to segregate into eye-specific domains and
generate relatively small terminals, both features of retinal
inputs to the IGL. To test our hypothesis we assessed the
distribution of neuropeptide Y (NPY) in vldlr−/−;lrp8−/−
mutant LGN. In wild-type LGN, NPY-expressing neurons

Su et al. Neural Development 2013, 8:11
http://www.neuraldevelopment.com/content/8/1/11

Page 8 of 16

Figure 5 Retinal terminals are smaller in the dorsomedial pole of vldlr−/−;lrp8−/−dLGN than throughout the rest of the dLGN. Retinal
terminals were labeled in (A) P14 control and (B) vldlr−/−;lrp8−/− mutant (DKO) LGN by VGluT2-immunostaining. In (B), note the ectopic region of
binocular retinal input in the dorsomedial pole of vldlr−/−;lrp8−/− dLGN is labeled with arrowheads. (C to I) High magnification images of
VGluT2-labeled terminals in control and mutant dLGN, IGL and vLGN. VGluT2-immunolabeled terminals in the dorsomedial pole of mutant dLGN
(dmdLGN) are shown in (I). Note that the size of VGluT2-containing terminals in dorsomedial pole of mutant dLGN are dramatically smaller than
those in dLGN (C,D) and instead appear similar to terminals in vLGN and IGL (E,F). (J) Terminals sizes were measured in ImageJ. Terminal areas
(in pixels2) were significantly larger in dLGN than in vLGN or IGL in controls. Terminal sizes in dorsomedial pole of mutant dLGN of DKO appeared
quantitatively similar to control vLGN and IGL. P <0.05 for terminal sizes in vLGN (control), IGL (control) and dorsomedial pole of mutant dLGN (DKO)
compared with dLGN (control) by ANOVA. Differences in terminal size between vLGN (control), IGL (control) and dorsomedial pole of mutant dLGN
(DKO) were not statistically significant. The outline of the dLGN is depicted with green dots. dLGN are labeled ‘d’, vLGN are labeled ‘v’ and arrows
indicate IGL. Scale bar = 160 μm for (A,B) and 30 μm for (C to I). Ctl, control; DKO, double knockout; dLGN, dorsal LGN; dmdLGN, dorsomedial pole of
mutant dLGN; IGL, intergeniculate leaflet; LGN, lateral geniculate nucleus; VGluT2, vesicular glutamate transporter 2; vLGN, ventral LGN.

are present in the IGL and are absent from all other
adjacent thalamic regions (Figure 7A,D). In vldlr−/−;
lrp8−/− mutants, NPY-expression was present in IGL
(although it appeared less organized than in controls),
but was also present in vLGN and in the dorsomedial pole
of the dLGN (Figure 7B,C,E,F). These results reveal that
IGL neurons are malpositioned in the dorsomedial pole of
the dLGN in vldlr−/−;lrp8−/− mutants.
These data suggest that classes of IGL projecting retinal
axons may target the dorsomedial pole of vldlr−/−;lrp8−/−
mutant dLGN due to the presence of malpositioned IGL
neurons. Based on our previous findings that indicated
reelin was a class-specific targeting cue for these axons,
we next addressed whether reelin distribution was altered

in vldlr−/−;lrp8−/− mutants. Reelin immunostaining was
performed on coronal sections of P3 vldlr−/−;lrp8−/−
mutant and littermate control brains. In every mutant
examined (n = 3) reelin-expressing cells were observed
in the dorsomedial pole of dLGN, as well as in regions
of dLGN directly adjacent to the optic tract (Figure 8).

Discussion
At the onset of these studies we hypothesized that deletion
of both VLDLR and LRP8 would result in defects in
retinogeniculate targeting that phenocopied those observed
in relnrl/rl mutants. At first glance at least three features
of retinal targeting in the LGN subnuclei appeared
similar in both sets of mutant mice. The size of retinal
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Figure 6 Abnormal cytoarchitecture of the dorsomedial pole of vldlr−/−;lrp8−/−mutant dLGN. Adamts15 mRNA, which is expressed by
thalamic relay neurons, was labeled by in situ hybridization in (A) P14 control and (B) vldlr−/−;lrp8−/− mutant (DKO) LGN. Retinal arbors were
labeled by binocular injection of Alexa Fluor 594 CTB. In (B), note the ectopic region of binocular retinal input in the dorsomedial pole of vldlr−/−;
lrp8−/− dLGN is labeled with arrowheads. Insets in (A,B) show high magnification images of the areas indicated by boxes. (C,D) dLGN and vLGN
relay neurons (and their dendrites) were labeled by SMI32-immunostaining and retinal terminals were labeled by VGluT2-IHC. Note the absence
of SMI32-immunoreactivity in the dorsomedial pole of vldlr−/−;lrp8−/− mutant dLGN (asterisk). Also note the abnormal presence of SMI32-IR
structures in vldlr−/−;lrp8−/− mutant IGL (arrowheads). Insets in (C,D) show high magnification images of the areas indicated by boxes, and single
and double asterisks. (E,F) Corticothalamic terminals in control and mutant dLGN were labeled by VGluT1-IHC. Retinal arbors were labeled by
binocular injection of Alexa Fluor 594 CTB. In (F), note the absence of VGluT1-immunoreactivity in the dorsomedial pole of vldlr−/−;lrp8−/− mutant
dLGN (arrowheads). Insets in (E,F) show high magnification images of the areas indicated by boxes. For all images, the outline of the dLGN is
depicted with white dots. dLGN are labeled ‘d’, vLGN are labeled ‘v’ and arrows indicate IGL. Scale bar = 180 μm for (A to F) and 50 μm for
insets. CTB, cholera toxin B subunit; Ctl, control; DKO, double knockout; dLGN, dorsal LGN; IGL, intergeniculate leaflet; LGN, lateral geniculate
nucleus; SMI32-IR, SMI32-immunoreactivity; VGluT1-IHC, vesicular glutamate transporter 1-immunohistochemistry; vLGN, ventral LGN.

projections to vLGN appeared reduced in vldlr−/−;lrp8−/−
mutants (Figure 2B,C), a defect previously noted in mutants
lacking either reelin or functional DAB1 (Figure 1B) [31].

In all of these cases it remains unresolved if these defects reflect reduced numbers of retinal axons targeting
vLGN, smaller terminal arbors of these axons, or smaller
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Figure 7 Malposition of IGL neurons in vldlr−/−;lrp8−/−mutant LGN. (A,B) NPY-expressing neurons, which are normally restricted to the IGL,
were immunolabeled in (A,D) P14 control and (B,C,E,F) vldlr−/−;lrp8−/− mutant (DKO) LGN. In (A to C), LGN neurons were colabeled by NeuN-IHC.
In (D to F), retinal arbors were colabeled by binocular injection of Alexa Fluor 594 CTB. Insets show high magnification images of the boxed areas
in (A to F). Note the presence of NPY-immunoreactivity in the dorsomedial pole of vldlr−/−;lrp8−/− mutant dLGN (as seen in insets). NPYimmunoreactivity also extended into the vLGN in vldlr−/−;lrp8−/− mutant LGN (arrowheads). For all images, the outline of the dLGN is depicted
with white dots. dLGN are labeled ‘d’, vLGN are labeled ‘v’ and arrows indicate IGL. Scale bar = 180 μm for (A to F) and 50 μm for insets. CTB,
cholera toxin B subunit; DKO, double knockout; dLGN, dorsal LGN; IGL, intergeniculate leaflet; IHC, immunohistochemistry; LGN, lateral geniculate
nucleus; Neu-N; neuronal nuclei; NPY, neuropeptide Y; vLGN, ventral LGN.
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Figure 8 Ectopic distribution of reelin in vldlr−/−;lrp8−/−mutant
LGN. Reelin distribution was assessed by immunostaining (A) P3
control and (B,C) vldlr−/−;lrp8−/− mutant (DKO) LGN. Insets show
high magnification images of the areas indicated by boxes. Note
in (B,C), the presence of reelin-immunoreactivity in the
dorsomedial pole of DKO mutant dLGN. For all images, the outline
of the dLGN is depicted with white dots. dLGN are labeled ‘d’,
vLGN are labeled ‘v’ and arrows indicate IGL. Scale bar = 180 μm
for (A to F) and 50 μm for insets. DKO, double knockout; dLGN,
dorsal LGN; IGL, intergeniculate leaflet; LGN, lateral geniculate
nucleus; vLGN, ventral LGN.
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retino-recipient nuclei. We also observed an absence of
retinal arbors in and adjacent to the IGL in vldlr−/−;lrp8−/−
mutants. Similar uninnervated regions of LGN were
observed in all reeler mutants examined and were
present in some, but not all, DAB1 mutants [31]. Despite
outward similarities in these two phenotypes in vldlr−/−;
lrp8−/−, relnrl/rl and dab1scm/scm mutant LGN, it is important to point out some minor differences. First,
the penetrance and strength of these two phenotypes
were reduced in receptor mutants compared with
those observed in mutants lacking reelin (Table 1).
The penetrance and strength was similarly reduced in
dab1scm/scm mutants [31] (unpublished data); however, a
small amount of residual DAB1 protein remains present
in these spontaneously generated mutant mice raising
the question of whether penetrance issues arise from
incomplete removal of DAB1. Second, in contrast to
relnrl/rl mutants, an organized set of projections to IGL
remained present (albeit reduced) in vldlr−/−;lrp8−/−
mutants (compare IGL in Figure 1B and [31] with those
in Figures 2B,C). Third, cytoarchitectural analysis revealed
differences in the molecular and cellular make-up of LGN
subnuclei in vldlr−/−;lrp8−/− and relnrl/rl mutants, a feature
that complicates comparisons of the retinogeniculate
projection phenotypes described above. Specifically,
our studies demonstrated that SMI32-IR neurons abnormally invaded IGL in the absence of VLDLR and
LRP8 (Figure 6), a phenotype not observed in mutants
lacking reelin [31]. Additionally NPY neurons, which
normally reside only in the IGL, migrate into the vLGN
and dLGN in the absence of VLDLR and LRP8 but not
in the absence of reelin (Figure 7) [31]. These results
are summarized in Figure 9.
The final similarity in abnormal retinal projections in
vldlr−/−;lrp8−/− and relnrl/rl mutants is an incomplete refinement of retinal terminals into eye-specific domains
(Figure 9), an essential feature in the establishment of
visual system circuits [1,42]. Impaired refinement of retinal
projections was also observed in dab1scm/scm, vldlr−/−, and
lrp8−/− mutants (Figure 1C,D and data not shown). Since
refinement of eye-specific arbors requires retinal activity,
defects in eye-specific segregation is not entirely unexpected in these mutants. Retinal activity has previously
been shown to be perturbed in the absence of reelin,
DAB1, VLDLR or LRP8 [43,44].
Despite the above described similarities in retinal
projections in vldlr−/−;lrp8−/− and relnrl/rl mutants, two
more notable differences in phenotypes were observed
in our studies. First, the deletion of both canonical
reelin receptors largely failed to generate bundles of
misrouted retinal axons that exited the medial borders
of the vLGN and IGL, and invaded non-retino-recipient regions of thalamus. Misrouting of axons from ipRGCs into
medial thalamus was a distinguishing feature of retinal

Su et al. Neural Development 2013, 8:11
http://www.neuraldevelopment.com/content/8/1/11

Page 12 of 16

Figure 9 VLDLR and LRP8 contribute to the cytoarchitecture and retinal targeting of mouse LGN. A diagram summarizing defects in
cytoarchitecture and retinal terminal distribution in mutant mice lacking both VLDLR and LRP8. dmdLGN, dorsomedial pole of dLGN; dLGN, dorsal
LGN; IGL, intergeniculate leaflet; LGN, lateral geniculate nucleus; LRP8, low-density lipoprotein receptor-related protein 8; RGC, retinal ganglion
cell; VLDLR, very-low-density lipoprotein receptor; vLGN, ventral lateral geniculate nucleus.

targeting in the absence of either reelin or DAB1 [20,31].
The lack of ipRGC axons erroneously exiting the medial
border of IGL in vldlr−/−;lrp8−/− mutants may help explain
why projections to the IGL in these double mutants
appears more developed than in relnrl/rl mutants. Second,
an ectopic region of binocular retinal input was observed
in the dorsomedial pole of vldlr−/−;lrp8−/− LGN (Figure 9),
a feature never observed in mutants lacking reelin or
functional DAB1 [31]. Cytoarchitectural analyses demonstrated that NPY-expressing IGL neurons aberrantly
migrate into this region of vldlr−/−;lrp8−/− dLGN, and
despite being displaced these cells generate a microdomain that is uniquely distinct from surrounding dLGN
and dorsal thalamus. Based on the density of NeuNpositive neurons in this micro-domain we suspect that
additional types of non-NPY expressing classes of IGL
neurons may also be present in this ectopic region.
Certainly, reelin-expressing cells, which normally populate
both IGL and vLGN [31], were present in this microdomain of mutant dLGN. In wild-type tissue, a cohort of
glial fibrillary acidic protein (GFAP)-expressing astrocytes
also populate IGL but not the surrounding tissue [45].
Surprisingly, we failed to observe GFAP-immunoreactivity
in the dorsomedial pole of vldlr−/−;lrp8−/− mutant dLGN,
suggesting that these cell populations were less affected
by the loss of VLDLR and LRP8 (data not shown), and
hinting that these glial cells are not the source of reelin in
the IGL. Based on the presence of IGL target neurons and
reelin in the dorsomedial pole of mutant dLGN, we posit
that IGL-projecting classes of retinal axons are misrouted
into this micro-domain of mutant dLGN. In support of
this hypothesis, retinal arbors in this micro-domain remain

unsegregated based on their eye of origin and form small
terminals, two features that are hallmarks of retinal projections in wild-type IGL. Taken together, data presented
here paint a picture that VLDLR and LRP8 have reelinindependent roles in the migration of IGL neurons during
thalamic development. Likewise, the lack of misrouted
ipRGC axons into medial thalamus suggests that reelin
signals through other receptors for the establishment of
class-specific retinogeniculate circuits.
What might these non-canonical reelin receptors be?
Despite the plethora of studies on reelin’s function in neural
development and synaptic function few receptors other
than VLDLR and LRP8 have been identified. Integrin α3β1
binds to the N-terminal f-spondin domain of reelin and can
activate DAB1 in a reelin-dependent manner [46,47]. Since
disruption in α3β1 signaling does not result in severe defects in neuronal position (like deletion of reelin or DAB1),
it has been suggested that reelin-α3β1 integrin interactions
may be more essential during neurite outgrowth, synapse
formation or synaptic function [47-49]. Based on its
established role in neurite extension [50,51] and expression in retinal axons [52], α3β1 integrin is a prime
candidate to mediate the class-specific axon targeting
function of reelin in mouse LGN. However, another prime
candidate for mediating reelin’s role in axon targeting
in the visual system is amyloid precursor protein (APP),
a transmembrane receptor with established roles in mediating neurite outgrowth [53,54] and synapse assembly
[55]. APP binds to the central repeating domain of reelin
(reelin repeats 3 to 6), an interaction that promotes neurite
outgrowth [56]. These findings, together with the fact that
APP is expressed by at least some mammalian RGCs [57],
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make APP a reasonable candidate for mediating the
class-specific axon targeting function of reelin in LGN.
The last non-canonical reelin receptor that we shall
discuss is the protocadherin cadherin-related neuronal
receptor 1 (CNR1) [58]. CNR1 remains a controversial
reelin binding partner [59,60], but due to isoform diversity and alternative splicing the cadherin superfamily
(which includes classical cadherins, protocadherins, FATfamily cadherins, T-cadherins and 7TM-cadherins) [58] has
been of particular interest for its role in the specific wiring
of neural circuits [61,62]. Based upon the expression of
many cadherins and protocadherins by RGCs, and the role
of classical cadherins in RGC axon targeting [63-66], CNR1
is an intriguing candidate receptor for mediating the classspecific axon targeting function of reelin in LGN.
Finally, what non-reelin ligand might bind and activate
VLDLR and LRP8 to affect neuronal migration during
thalamic development? Since both VLDLR and LRP8 are
members of the LDL family of lipoprotein receptors they
can bind a variety of lipoproteins including compounds
containing apolipoprotein E (ApoE). ApoE has been
shown to affect cell migration in a variety of systems
[67], suggesting it may be the LGN ligand for VLDLR
and LRP8. However, other candidate extracellular ligands
with known roles in cell migration have also been identified. Both canonical reelin receptors are also capable of
binding thrombospondin (THBS), a bulky extracellular
proteoglycan present in the developing brain [68,69]. Like
reelin, binding of THBS to VLDLR and LRP8 activates
DAB1, but the subsequent downstream signaling events
differ from that of reelin induced signals [68]. Our previous
studies identified an isoform of THBS, THBS4, as being
one of the extracellular cues most significantly enriched
in vLGN/IGL compared with dLGN at perinatal ages of
mouse development [31]. Roles for thrombospondins in
LGN development remain unresolved.

Conclusions
Identifying the molecular underpinnings of class-specific
targeting of axons to correct brain regions is essential
for our understanding of how complex neural circuits
are assembled. Visual system circuits are ideal models to
study class-specific axonal targeting since there are over
20 distinct classes of RGCs in the mammalian retina,
each with a unique stereotyped pattern of axonal projections to a cohort of retino-recipient nuclei within the
brain [11-19,70-73]. Such diversity of neuronal subtypes
and class-specific circuitry is not unique to the retina,
but instead is a central feature of many regions of the
mammalian brain. In a previous study we identified
reelin, a bulky extracellular proteoglycan, as a critical
molecular component required for the targeting of LGN
subnuclei by distinct classes of retinal axons. Here we
addressed whether this function of reelin required the
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two canonical reelin receptors, VLDLR and LRP8. While
genetic deletion of either VLDLR or LRP8 had little
affect on the initial targeting of retinal axons to LGN
subnuclei (despite clear affects on the refinement of
these axons into segregated, eye-specific domains), several
defects were observed in retinal axon targeting in mutant
mice lacking both receptors. However, in contrast to our
hypothesis that reelin would utilize these receptors for
class-specific retinogeniculate targeting, we found that
deletion of both canonical reelin receptors failed to accurately phenocopy retinal targeting defects present in
relnrl/rl mutant LGN. The misrouting of retinal axons
into medial, non-retino-recipient thalamus in the absence of reelin were not observed in vldlr−/−;lrp8−/−
mutants and aberrant patterns of retinal projections
seen in vldlr−/−;lrp8−/− mutants (which appeared secondary to defects in neuronal migration) were not observed in mutants lacking reelin. We take these results
to suggest that non-canonical reelin receptors contribute to reelin’s role in retinogeniculate targeting, and
other extracellular ligands activate VLDLR and LRP8
for the proper migration of IGL neurons.

Methods
Mice

Wild-type C57 mice were obtained from Charles River
(Wilmington, MA, USA). Reeler mutant mice (relnrl/rl),
vldlr−/− and lrp8−/−mice were obtained from The Jackson
Laboratory (Bar Harbor, ME, USA). Genomic DNA was
isolated from tail and genotyping performed as previously
described [31,74-76]. The following primer pairs were
used: reln, TTA ATC TGT CCT CAC TCT GCC CTC T
and GCA GAC TCT CTT ATT GTC TCT AC; mutant
reln, TTA ATC TGT CCT CAC TCT GCC CTC T and
TTC CTC TCT TGC ATC CTG TTT TG [73]; vldlr,
TGG TGA TGA GAG GCT TGT ATG TTG TC and
TTG ACC TCA TCG CTG CCG TCC TTG; mutant
vldlr, CGG CGA GGA TCT CGT CGT GAC CCA and
GCG ATA CCG TAA AGC ACG AGG AAG; lrp8, CCA
CAG TGT CAC ACA GGT AAT GTG and ACG ATG
ACC CCA ATG ACA GCA GCG; mutant lrp8, GAT
TGG GAA GAC AAT AGC AGG CAT GC and GCT
TGT TGG AAT TCA GCC AGT TAC C. All analyses
conformed to National Institutes of Health (NIH)
guidelines and protocols, approved by the Virginia
Polytechnic Institute and State University, and Virginia
Commonwealth University (VCU) Institutional Animal
Care and Use Committees.
Antibodies

Antibodies for the following antigens were purchased:
rabbit anti-VGluT2 and rabbit anti- VGluT1 (diluted 1:500;
Synaptic Systems, Göttingen, Germany), mouse anti-reelin
(diluted 1:1000; Abcam, Cambridge, UK), rabbit anti-NPY
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(diluted 1:500; ImmunoStar, Hudson, WI, USA), mouse
anti-NeuN (diluted 1:200; Millipore, Billerica, MA, USA),
rabbit anti-glutamate decarboxylase 65/67 (GAD65/67)
(diluted 1:500; Millipore Bioscience Research Reagents,
Temecula, CA, USA), and mouse anti-SMI32 (diluted 1:500;
Covance, Princeton, NJ, USA). Fluorescently conjugated
secondary antibodies were purchased from Invitrogen
(Carlsbad, CA, USA) or Jackson ImmunoResearch (diluted
1:1000; West Grove, PA, USA).
Immunohistochemistry

Immunohistochemistry (IHC) was performed on 16 μm
coronal cryosectioned tissues as previously described
[31,38,74,76]. Briefly, tissue slides were allowed to air
dry for 15 minutes before being incubated with blocking
buffer (2.5% normal goat serum, 2.5% bovine serum
albumin and 0.1% Triton X-100 in PBS) for 30 minutes.
Primary antibodies were diluted in blocking buffer and
incubated on tissue sections for overnight at 4°C. On the
following day, tissue slides were washed in PBS and
secondary antibodies diluted 1:1000 in blocking buffer
were applied to slides for 1 hour at room temperature.
After thoroughly washing in PBS, tissue slides were
coverslipped with VectaShield (Vector Laboratories,
Burlingame, CA, USA). Images were acquired on a Zeiss
Axio Imager A2 fluorescent microscope, a Zeiss Examiner
Z1 LSM 710 confocal microscope, or a Zeiss LSM 700
confocal microscope (Oberkochen, Germany). When
comparing different ages of tissues or between genotypes, images were acquired with identical parameters.
The size of VGluT2-immunoreactive retinal terminals
was measured with ImageJ (NIH, Bethesda, MD, USA).
The area of individual puncta in control and mutant vLGN,
IGL and dLGN were measured manually. A minimum of
three animals (per genotype and per age) was compared in
all IHC experiments.
In situ hybridization

In situ hybridization (ISH) was performed on 16 μm coronal
cryosectioned tissues as previously described [31,74,76]. The
generation of adamts15 (clone IDs 30619053) riboprobes
was previously described [31]. Briefly, riboprobes were
synthesized using digoxigenin (DIG)-labeled UTP (Roche,
Mannheim, Germany) and the MAXIscript In Vitro
Transcription Kit (Ambion, Austin, TX, USA). Probes
were hydrolyzed to 500 nt. Coronal brain sections were
prepared and hybridized at 65°C as previously described
(Su et al., 2010), and bound riboprobes were detected
by horseradish peroxidase (POD)-conjugated anti-DIG
antibodies and fluorescent staining with Tyramide Signal
Amplification (TSA) systems (PerkinElmer, Shelton, CT,
USA). Images were obtained on a Zeiss Axio Imager
A2 fluorescent microscope or a Zeiss Examiner Z1
LSM 710 confocal microscope. A minimum of three
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animals per genotype and age was compared in ISH
experiments.
Intraocular injections of anterograde tracers

Intraocular injection of CTB conjugated to Alexa Fluor
488 or Alexa Fluor 594 (Invitrogen) was performed as
previously described [31,39]. Briefly, mice were anesthetized with hypothermia (<P7) or by isoflurane vapors
(>P7). The sclera was pierced with a sharp-tipped glass
pipette and excess vitreous was drained. Another pipette,
filled with a 0.1 to 0.2% solution of CTB, was inserted into
the hole made by the first pipette. The pipette containing
the CTB was attached to a picospritzer and a prescribed
volume (1 to 3 μl at P3 to P10 and 3 to 5 μl for ages >P10)
of solution was injected into the eye. After 1 to 2 days, mice
were killed and brains were fixed in 4% paraformaldehyde.
A total of 100 μm coronal sections were sectioned on
a vibratome (Microm HM 650 V; Thermo Scientific,
Waltham, MA, USA) and mounted in ProLong Gold
(Invitrogen). Retinal projections were analyzed from
between 3 to 12 animals for each age and genotype.
Images were acquired on a Zeiss Examiner Z1 LSM
710 confocal microscope or a Zeiss LSM 700 confocal
microscope. We documented four types of defects in
retinogeniculate targeting in wild-type (control), relnrl/rl,
vldlr−/−, lrp8−/−, vldlr−/−;lrp8−/−, vldlr−/−;lrp8+/− and vldlr+/−;
lrp8−/− mice: 1) smaller pattern of retinal projection to
vLGN; 2) an absence of retinal axons between vLGN
and IGL; 3) retinal axons abnormally exiting the medial
border of the vLGN with IGL; and 4) retinal axons from
both ipsilateral and contralateral retinas that ectopically
innervate to the dorsomedial pole of dLGN. We scored
these phenotypes objectively based on penetrance and
subjectively based on robustness. All sections were scored
blind by at least two observers.
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